Aladdin Healthcare Technologies SE

Equities

NMI

DE000A12ULL2

Healthcare Facilities & Services

End-of-day quote BOERSE DUESSELDORF 06:00:00 2024-04-23 pm EDT 5-day change 1st Jan Change
0.0015 EUR 0.00% Intraday chart for Aladdin Healthcare Technologies SE -25.00% 0.00%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Aladdin Healthcare Technologies Up 28% On OTCBQ Market Listing Approval MT
Aladdin Healthcare Technologies SE Reports Earnings Results for the Half Year Ended June 30, 2021 CI
Aladdin Healthcare Technologies Se Reports Earnings Results for the Full Year Ended December 31, 2020 CI
Aladdin Healthcare Technologies Jointly Develops Ai-Platform for Cardiovascular Diseases That Achieves Three Patents in China CI
Aladdin Healthcare Technologies SE Signs Memorandum of Understanding with Consentia Ltd CI
Aladdin Healthcare Technologies Se Reports Earnings Results for the Full Year Ended December 31, 2019 CI
Aladdin Healthcare Technologies SE Discovers Anti-Osteoporosis Nanomolar Activity CI
Aladdin Healthcare Technologies Completes Biomedical Knowledge Graph for Commercial Use in Drug Development CI
Aladdin Healthcare Technologies SE Validates Its Proprietary Deep Learning Algorithms CI
Aladdin Healthcare Technologies SE Develops Fully Automated Deep Learning Process to Detect and Distinguish Covid-19 from Other Diseases from CT Images CI
Aladdin Healthcare Technologies SE Gains Approval by the Dementias Platform UK for Accessing Important Biobanks Containing A Huge Amount of Medical Data for Dementia Research CI
Aladdin Healthcare Technologies Sets Up Joint Venture with Chinese Partner Network CI
Aladdin Healthcare Technologies SE Launches Its Health Risk Assessment Tool to Airbus and Saregama CI
Aladdin Healthcare Technologies Se Outperforms in the First Quarter 2020 and Achieves Major Milestones Earlier Than Planned CI
Aladdin Healthcare Technologies SE Launches its Prototype 'Health Risk Assessment Tool' for COVID-19 in India CI
Aladdin Healthcare Technologies SE Delivers Thermo-Imaging AI System for COVID-19 Coronavirus and Early Virus Mass Detection CI
Aladdin Healthcare Technologies SE Signs MOU with Partner in India to Validate and Distribute COVID-19 Diagnosis Prototype CI
Aladdin Healthcare Technologies Develops a Novel Prototype Application for More Accurate Real-Time Diagnosis of Covid-19 Corona Virus CI
Aladdin Healthcare Technologies SE Announces the Appointment of David C. Rubinsztein as Chief Scientific Advisor CI
Aladdin Healthcare Technologies SE Develops a Prototype A.I Powered Data Analysis Platform for Brain Imaging CI
Aladdin Healthcare Technologies SE Release SAAS Prototype for Early Diagnosis of Alzheimer's Disease Based on Blood Test Results CI
Aladdin Healthcare Technologies SE Announces It Has Entered into A Memorandum of Understanding with Imperial Institute of Advanced Technology CI
Aladdin Healthcare Technologies Se Reports Earnings Results for the Full Year Ended December 31, 2018 CI
Aladdin Healthcare Technologies Signs Partnership Agreement with the Norweigan Centre of Healthy Ageing CI
Aladdin Healthcare Technologies SE Announces the 2.3 Million Anonymised EMRS on its Platforms Globally CI
Chart Aladdin Healthcare Technologies SE
More charts
Aladdin Healthcare Technologies SE is a Germany based provider of health care services with the help of Artificial Intelligence. It operates as a healthcare technology company, which develops and builds AI technology diagnostics and health screening services such as blood testing, advanced image processing, and analysis of age-related diseases. The Company serves clients worldwide.
More about the company
  1. Stock Market
  2. Equities
  3. NMI Stock
  4. News Aladdin Healthcare Technologies SE
  5. Aladdin Healthcare Technologies Up 28% On OTCBQ Market Listing Approval